HDIM
VIRX
Hanson & Doremus Investment Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-166
| Closed | – | – | 523 |
|
|
2018
Q1 | $0 | Hold |
166
| – | – | ﹤0.01% | 514 |
|
|
2017
Q4 | $1K | Hold |
166
| – | – | ﹤0.01% | 492 |
|
|
2017
Q3 | $0 | Hold |
166
| – | – | ﹤0.01% | 504 |
|
|
2017
Q2 | $0 | Hold |
166
| – | – | ﹤0.01% | 501 |
|
|
2017
Q1 | $1K | Hold |
166
| – | – | ﹤0.01% | 469 |
|
|
2016
Q4 | $601 | Hold |
166
| – | – | ﹤0.01% | 453 |
|
|
2016
Q3 | $1K | Sell |
166
-834
| -83% | -$5.02K | ﹤0.01% | 440 |
|
|
2016
Q2 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 438 |
|
|
2016
Q1 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 452 |
|
|
2015
Q4 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 462 |
|
|
2015
Q3 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 447 |
|
|
2015
Q2 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 428 |
|
|
2015
Q1 | $2K | Buy |
+1,000
| New | +$2K | ﹤0.01% | 447 |
|